Enforcement Report - Week of December 7, 2022
Dr. Reddy’s Launches OTC, Store-Brand Equivalent of Allegra-D in U.S.
Enforcement Report - Week of January 26, 2022
Enforcement Report - Week of January 12, 2022
Enforcement Report - Week of December 29, 2021
Enforcement Report - Week of December 15, 2021
SAO PAULO, Sept. 13, 2021 /PRNewswire/ -- Allegra, Brazil's best-selling anti-allergy, debuts the continuation of the campaign for its Allegra Pediatric line, which provides rapid relief from allergy symptoms* and does not make you sleepy, without harm school performance²-³, and does not disconnect children from learning?.
Ind-Swift Laboratories Limited is all set to commercially launch its key API - fexofenadine, an anti-histamine drug used for the treatment of seasonal allergic rhinitis and urticaria in US market.
The FDA on Wednesday said it is requiring a boxed warning and medication guide for Merck’s asthma and allergy drug Singulair (montelukast) and its generics to strengthen existing warnings about the risk of neuropsychiatric events, including suicides, linked to the drug.
The US Food and Drug Administration (FDA) on Wednesday said it is requiring a boxed warning and medication guide for Merck’s asthma and allergy drug Singulair (montelukast) and its generics to strengthen existing warnings about the risk of neuropsychiatric events, including suicides, linked to the drug.